Intellectual Property India Publishes Patent Application for “sustained Release Pharmaceutical Composition Comprising Ruxolitinib And Process For Preparation Thereof”

MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202541019880 A) filed by Granules India Limited on March 05, 2025, for “sustained Release Pharmaceutical Composition Comprising Ruxolitinib And Process For Preparation Thereof”.

Inventors include Krishna Prasad Chigurupati; Manikandan Ramalingam; Rajesh Thipparaboina; and Shailendra Mangde.

The application for the patent was published on September 11, 2026, under issue no. 37/2026.

Abstract: ABSTRACT “SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING RUXOLITINIB AND PROCESS FOR PREPARATION THEREOF” The present invention relates to sustained release pharmaceutical composition comprising Ruxolitinib or its pharmaceutically acceptable salts, release retarding agents selected from stearates, glyceryl dibehenate and methacrylic acids and methacrylic acid copolymers . Further the invention is related to process for the preparation of sustained release composition comprising Ruxolitinib or its pharmaceutically acceptable salts. Dated this: 4th day of March, 2026. Signature: Name: Mr. Rama Rao Javvaji Patent Agent Reg. No.: IN/PA-1669 GRANULES INDIA LIMITED 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad, Telangana, INDIA-500 084.

Disclaimer: Curated by HT Syndication.